Jason Grebely

ORCID: 0000-0002-1833-2017

Also affiliated with Sydney Orthopaedic Research Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study”.

Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study

The Lancet. Gastroenterology & hepatology(2021)10.1016/s2468-1253(21)00077-7

N/A

2.4DataRank · unranked

98 citations

Jason Grebely, Marianne Byrne, Pip Marks, Janaki Amin, Hamish McManus +46 more

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

International Journal of Drug Policy(2021)10.1016/j.drugpo.2021.103492

N/A

2.1DataRank · unranked

52 citations

Jeyran Shahbazi, Marianne Byrne, Jason Grebely, Nicholas Lintzeris, Mark S. Chambers +13 more

Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection

Journal of Hepatology(2021)10.1016/j.jhep.2021.04.056

N/A

1.3DataRank · unranked

49 citations

Sanjay Bhagani, Marc van der Valk, Juergen Rockstroh, Andri Rauch, Christine Thurnheer +33 more

96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial

International Journal of Drug Policy(2024)10.1016/j.drugpo.2024.104390

N/A

0.730DataRank · unranked

21 citations

Jeyran Shahbazi, Mark S. Chambers, Marianne Byrne, Jaleh Gholami, Emma Zahra +14 more

Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence

JAMA Psychiatry(2021)10.1001/jamapsychiatry.2021.0976

N/A

0DataRank · unranked

589 citations

Brodie Clark, Matthew Hickman, Jason Grebely, Gabrielle Campbell, Luis Sordo +14 more

Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP‐C Treatment as Prevention Study in Prisons

Hepatology(2021)10.1002/hep.32002

N/A

0DataRank · unranked

19 citations

Jack Stone, Behzad Hajarizadeh, Marianne Byrne, Georgina Chambers, Natasha K. Martin +5 more

Reinfection incidence and risk among people treated for recent hepatitis C virus infection

AIDS(2023)10.1097/qad.0000000000003651

N/A

0DataRank · unranked

13 citations

Joanne Carson, Marc van der Valk, Jürgen K. Rockstroh, Patrick Ingiliz, Margaret Hellard +18 more

Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis

The Lancet Microbe(2023)10.1016/s2666-5247(23)00108-8

N/A

0DataRank · unranked

10 citations

Gail Matthews, Juergen Rockstroh, Tanya Applegate, Sanjay Bhagani, Andri Rauch +83 more

A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles

The Lancet. Gastroenterology & hepatology(2025)10.1016/s2468-1253(25)00068-8

N/A

0DataRank · unranked

20 citations

Jana Manning, Rania A. Tohme, Maria Buti, Loreta A. Kondili, C Wendy Spearman +36 more

The People-First Liver Charter

Nature Medicine(2025)10.1038/s41591-025-03759-8

N/A

0DataRank · unranked

16 citations

Dana Ivancovsky‐Wajcman, Silvana Pannain, Paul Brennan, Melina I. Manolas, Peter Jepsen +35 more

Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis

Clinical Infectious Diseases(2020)10.1093/cid/ciaa612

N/A

0DataRank · unranked

77 citations

Lucy Thi Tran, Louisa Degenhardt, Alexander Dowell‐Day, Thomas Santo, Sarah Larney +10 more

A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles

The Lancet. Gastroenterology & hepatology(2025)10.1016/s2468-1253(25)00069-x

N/A

0DataRank · unranked

12 citations

Jana Manning, Rania A. Tohme, Maria Buti, Loreta A. Kondili, C Wendy Spearman +36 more

Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study

Clinical Infectious Diseases(2020)10.1093/cid/ciaa571

N/A

0DataRank · unranked

75 citations

Maryam Alavi, D. B. A. Silk, Carla Treloar, Marianne Martinello, Andrew Milat +14 more

Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis

International Journal of Drug Policy(2020)10.1016/j.drugpo.2020.102866

N/A

0DataRank · unranked

35 citations

Amy Peacock, Samantha Colledge‐Frisby, Sonja Memedovic, Jason Grebely, Janni Leung +7 more

Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic review

Drug and Alcohol Dependence(2020)10.1016/j.drugalcdep.2020.107899

N/A

0DataRank · unranked

4 citations

Janni Leung, Jason Grebely, Louisa Degenhardt, Amy Peacock, Matthew Hickman +5 more